Anti-inflammatory treatments for stroke: from bench to bedside

被引:69
|
作者
Drieu, Antoine [1 ]
Levard, Damien [1 ]
Vivien, Denis [1 ,2 ]
Rubio, Marina [1 ]
机构
[1] Normandy Univ, Pathophysiol & Imaging Neurol Disorders, Blvd Henri Becquerel BP 5229, F-14000 Caen, France
[2] CHU Caen, Imaging Neurol Disorders, Caen, France
关键词
clinical trial; immunomodulatory drugs; inflammation; stroke models; translation; ACUTE ISCHEMIC-STROKE; REGULATORY T-CELLS; FOCAL CEREBRAL-ISCHEMIA; SPINAL-CORD-INJURY; INTERLEUKIN-1 RECEPTOR ANTAGONIST; IMMUNE MODULATOR FINGOLIMOD; SENSITIVE MOLECULAR MRI; CENTRAL-NERVOUS-SYSTEM; REDUCES BRAIN-DAMAGE; THROMBOEMBOLIC STROKE;
D O I
10.1177/1756286418789854
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
So far, intravenous tissue-type plasminogen activator (tPA) and mechanical removal of arterial blood clot (thrombectomy) are the only available treatments for acute ischemic stroke. However, the short therapeutic window and the lack of specialized stroke unit care make the overall availability of both treatments limited. Additional agents to combine with tPA administration or thrombectomy to enhance efficacy and improve outcomes associated with stroke are needed. Stroke-induced inflammatory processes are a response to the tissue damage due to the absence of blood supply but have been proposed also as key contributors to all the stages of the ischemic stroke pathophysiology. Despite promising results in experimental studies, inflammation-modulating treatments have not yet been translated successfully into the clinical setting. This review will (a) describe the timing of the stroke immune pathophysiology; (b) detail the immune responses to stroke sift-through cell type; and (c) discuss the pitfalls on the translation from experimental studies to clinical trials testing the therapeutic pertinence of immune modulators.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Interleukin-1 in Stroke From Bench to Bedside
    Sobowale, Oluwaseun A.
    Parry-Jones, Adrian R.
    Smith, Craig J.
    Tyrrell, Pippa J.
    Rothwell, Nancy J.
    Allan, Stuart M.
    STROKE, 2016, 47 (08) : 2160 - 2167
  • [2] Cholinergic Anti-inflammatory Pathway and Stroke
    Duris, Kamil
    Lipkova, Jolana
    Jurajda, Michal
    CURRENT DRUG DELIVERY, 2017, 14 (04) : 449 - 457
  • [3] Novel Anti-inflammatory and Anti-fibrotic Agents for Diabetic Kidney Disease-From Bench to Bedside
    Nicholas, Susanne B.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2021, 28 (04) : 378 - 390
  • [4] Neuroprotection for ischaemic stroke: Translation from the bench to the bedside
    Sutherland, Brad A.
    Minnerup, Jens
    Balami, Joyce S.
    Arba, Francesco
    Buchan, Alastair M.
    Kleinschnitz, Christoph
    INTERNATIONAL JOURNAL OF STROKE, 2012, 7 (05) : 407 - 418
  • [5] Anti-Inflammatory Targets for the Treatment of Reperfusion Injury in Stroke
    Mizuma, Atsushi
    Yenari, Midori A.
    FRONTIERS IN NEUROLOGY, 2017, 8
  • [6] The potential use of mesenchymal stem cells in stroke therapy-From bench to bedside
    Dulamea, Adriana Octaviana
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 352 (1-2) : 1 - 11
  • [7] Neuroinflammation and anti-inflammatory therapy for ischemic stroke
    Cao, Yangyue
    Yue, Xuanye
    Jia, Meng
    Wang, Jiawei
    HELIYON, 2023, 9 (07)
  • [8] Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine for Prevention of Chronic Diseases: "Reverse Pharmacology" and "Bedside to Bench" Approach
    Aggarwal, Bharat B.
    Prasad, Sahdeo
    Reuter, Simone
    Kannappan, Ramaswamy
    Yadav, Vivek R.
    Park, Byoungduck
    Kim, Ji Hye
    Gupta, Subash C.
    Phromnoi, Kanokkarn
    Sundaram, Chitra
    Prasad, Seema
    Chaturvedi, Madan M.
    Sung, Bokyung
    CURRENT DRUG TARGETS, 2011, 12 (11) : 1595 - 1653
  • [9] Acute anti-inflammatory approaches to ischemic stroke
    del Zoppo, Gregory J.
    INNATE INFLAMMATION AND STROKE, 2010, 1207 : 143 - 148
  • [10] Neuroinflammation and Neuroprotective Strategies in Acute Ischaemic Stroke - from bench to bedside
    Shah, Imtiaz M.
    Macrae, I. Mhairi
    Di Napoli, Mario
    CURRENT MOLECULAR MEDICINE, 2009, 9 (03) : 336 - 354